AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

IOFINA PLC

Board/Management Information Sep 5, 2014

7716_rns_2014-09-05_90d4135a-c3a4-42ae-8401-236542c2270d.html

Board/Management Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9114Q

Iofina PLC

05 September 2014

September 5, 2014

Iofina plc

("Iofina" or the "Company")

(LSE AIM: IOF)

Appointment of CEO

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, is pleased to announce the appointment of Dr. Thomas M. Becker as President & CEO of the Company effective immediately. Company co-founder Mr. Jeffery Ploen, will return to his role as Non-Executive Director.

Dr. Becker is a current Executive Director of the Company and the President/CEO of Iofina Chemical, Inc. Under his four years of management, Iofina Chemical has experienced record expansion, revenues and profits.  Dr. Becker is a recognized expert in the global iodine market and has extensive production knowledge of iodine and iodine derivatives. Dr. Becker holds a PhD from the University of Cincinnati and a BS from Indiana University, both in Chemistry. 

Lance J Baller, co-founder and Non-Executive Chairman commented: "Tom has shown he is the ideal candidate to lead Iofina through its next stage of development.  His proven success at Iofina Chemical and extensive knowledge and connections within the global iodine industry are well recognised.  Tom's leadership will guide Iofina forward as we continue to grow and optimize our company-wide operations."

For further information, please contact:

Lance Baller, Non-Executive Chairman

Dr. Tom Becker, President & CEO

Iofina

Tel: +44 (0) 20 3006 3135

John Prior/Rupert Krefting/Paul Gillam

Numis Securities

Tel: +44 (0)20 7260 1000

Rob Collins/Emily Morris/Liz Williamson

GMP Securities

Tel: +44(0)20 7647 2800

Dominic Barretto/Anna Legge

Yellow Jersey PR

Tel: +44 (0)7768 537 739

About Iofina:

Iofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives and produced water. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb® technology. Iofina has production operations in the United States, specifically in Texas, Montana, Kentucky and Oklahoma. It has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end-products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes in Europe, North America and Asia. Iofina utilizes its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

www.iofina.com  

This information is provided by RNS

The company news service from the London Stock Exchange

END

BOAUGUAWBUPCGBC

Talk to a Data Expert

Have a question? We'll get back to you promptly.